Home
News
Press Releases and Articles
Calendar of Events
How to Help
Gates Foundation Grant to GAELF
The Global Alliance
Global Alliance History
Goals
Global Alliance Structure
Executive Group
Partnerships
GAELF Logo
LF Webring
About LF
What is LF?
How is LF Contracted?
How is LF Diagnosed?
Prevent/Eliminate LF
Manage LF
LF and Children
Additional Treatment Benefits
LF Slideshow
In Depth Disease Info
Where is LF?
Countries and Map List
Moving Forward
Starting Out
Success Stories
Progress and Plans
Elimination Strategy
Operational Research
Progress to Date
Economics of LF
Return on Investment
The Way Ahead
Highlighted Programmes
   Burkina Faso
   Sri Lanka

For the Media
Press Release Archive
Press Kits
Photos
Articles
Video Clips
Media Contacts
FAQs
Publications
LF News
Annual Reports
General Publications
Training Material
Videos
Journal Articles & Other Pubs
EG Updates
Gates Foundation

Asymptomatic Presentations

Of all the individuals with lymphatic filariasis less than half appear clinically asymptomatic, though they have microfilariae circulating in their blood and yet all have hidden damage to their lymphatic (as evidenced by lymphoscintigraphy) and/or renal systems (microscopic heamaturia and/or proteinuria). It is clear that this state of asymptomatic microfilaraemia is associated with a highly down-regulated immune system, but it is as yet unclear how, when or even whether these individuals will progress to develop one of the more overt clinical manifestations of filarial disease.

A second asymptomatic 'presentation' exists in individuals previously termed 'endemic normals'; their infections are defined not by microfilaraemia but by the presence of parasite antigen in the blood (which will disappear after appropriate treatment). It has only recently been possible to recognize this group of patients, and both their clinical features and sequelae of infection remain to be defined.

 

© Global Alliance to Eliminate Lymphatic Filariasis